or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia
syndrome characterized by bidirectional or polymorphic ventricular arrhythmias under …

Objectives: This study evaluated the efficacy and safety of flecainide in addition to
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …

Background—Catecholaminergic polymorphic ventricular tachycardia is an uncommon,
potentially lethal, ion channelopathy. Standard therapies have high failure rates and little is …

Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized
by adrenergically induced ventricular tachycardia (VT) associated with syncope and sudden …

In the early nineties, few years before the birth of Europace, the clinical and scientific world
of familial arrhythmogenic conditions was revolutionized by the identification of the first …

Background—Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited
arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene …

Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an
inheritable cardiac disease predisposing to malignant ventricular arrhythmias. Objective We …

The ryanodine receptors (RyRs) is the major intracellular Ca 2+ release channel localized in
the plasma membrane of the endoplasmatic/sarcoplasmatic reticulum. RyR-mediated Ca 2+ …

Sudden cardiac death (SCD) is predominantly related to coronary artery disease and its
sequelae, cardiomyopathy, and congenital or valvular heart disease. No structural …